Concepedia

Debasmita Roy

DR

Statistics

Publications

13

Citations

896

H-Index

13

Active since

2006

Affiliations

University of North Carolina at Chapel Hill(Current)

New York University

University of Pittsburgh

University of Miami

Beth Israel Deaconess Medical Center

Debasmita Roy is an author at University of North Carolina at Chapel Hill specializing in medicine, molecular oncology, and oncology.

Publications per year

2006–2018

13

Publications

13

Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling

Sang‐Hoon Sin, Debasmita Roy, Ling Wang et al. · Blood · 2006 · 175 citations · Full text

, , +10

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas

Aadra P. Bhatt, Prasanna M. Bhende, Sang‐Hoon Sin et al. · Blood · 2010 · 147 citations · Full text

, , +13

Replication fork regression in repetitive DNAs

Nicole Fouché, Sezgin Özgür, Debasmita Roy et al. · Nucleic Acids Research · 2006 · 100 citations · Full text

, , +16

Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines

Debasmita Roy, Sang‐Hoon Sin, Blossom Damania et al. · Blood · 2011 · 84 citations · Full text

, , +16

mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis

Debasmita Roy, Sang‐Hoon Sin, Amy Lucas et al. · Cancer Research · 2013 · 79 citations · Full text

, , +17

1–5 of 13